Report Overview

Drug screening is a diagnostic test used to examine biological samples such as blood, hair, and urine to detect the presence of drug abuse or its metabolites in a person’s body. Drug screening tests are used to establish whether a suspected person is or was under the influence of effects of the drug at a certain period. It is used in organizations to monitor their employees and in the sports industry to detect drug abuse in athletes.

Global Drug Screening Market - Industry Trends & Forecast Report 2027

The global Drug Screening Market was worth USD 4.47 Billion in 2020, and it is further projected to reach a valuation of USD 14.14 Billion by 2027, at a CAGR of 18.6% during 2021-2027 (forecast period). The surge in market demand can be attributed to the increased necessity for the execution of rigorous regulations demanding drug and alcohol testing. The possibility of government support in this industry has also resulted in the worldwide drug screening market being promoted. However, the ban on alcohol consumption in some Islamic countries has reduced the demand for drug screening in many regions. The prohibition of drug testing at the workplace is also a restraining factor in further expansion of market growth.

Source: BlueWeave Consulting

Drug Screening Market Overview

Drug screening is a diagnostic test used to examine biological samples such as blood, hair, and urine to detect the presence of drug abuse or its metabolites in a person’s body. Drug screening tests are used to establish whether a suspected person is or was under the influence of effects of the drug at a certain period. It is used in organizations to monitor their employees and in the sports industry to detect drug abuse in athletes. The market's growth can be attributed to its widespread use in the workplace, criminal justice systems, law enforcement agencies, drug treatment clinics, the laboratory sector, and hospitals. For example, companies regulated by the United States Department of Transportation are subject to federal or state drug testing laws. However, the banning of drug testing in many organizations has resulted in a drop in the drug screening market's demand.

Drug Screening Market Trends

Growth Drivers

Concern Over Increasing Alcohol and Drug Consumption Has Created A Demand for The Market.

Global alcohol use and drug abuse have recently surged, which is cause for concern. Around 192 million people are consuming cannabis according to UN World Drug Report 2020. Over the last few years, the rate of opioid misuse mortality has risen by up to 71%. The cost of drug use is equivalent to losing 28 million years of healthy life. These startling figures are comparable to the rate of alcohol consumption. As a result, the number of accidents caused by drunk driving has increased. These alarming numbers are similar to the alcohol consumption rate. This has resulted in a rising incidence of accidents due to drunk driving. According to National Crime Records Bureau, around 12,256 road accidents related to drunk driving occurred in 2019 in India alone. To curb this menace of alcohol and drug abuse, the demand for the drug screening market has increased. Also, governments and agencies of many countries are working towards initiatives to expand this market and regulate their concern. 

Market Opportunities Are Rising Due to The Adoption Of Innovative Methods.

The launch of new products and development in drug screening has created immense opportunities for the growth of the global drug screening market. Apart from alcohol and drug testing, it is being applied in clinical and research studies as well. For example, carvedilol was identified as a possible therapy for retinitis pigmentosa through drug screening utilizing zebrafish visual behavior. The incorporation of new technology into various analytical instruments such as spectroscopic devices and inhalers has improved the drug screening market's services. An increase in government financing for drug testing, as well as increased public awareness of its use, has increased market demand around the world. For example, the United States has strict drug-abuse regulations and requires alcohol and drug testing through the Drug-Free Workplace Act.

Restraints

Prohibition of A Drug Screening In Several Organizations

Many countries such as Canada, Colombia, Argentina, Chile, and South Africa consider alcohol and drug testing in the workplace as a violation of employees' privacy. These organizational policies have hindered the growth of the drug screening market by affecting demand.  For instance, drug and alcohol testing in the workplace is strictly prohibited in Poland and the Czech Republic. This lack of demand from the largest end-user market, i.e., the workplace, has hampered the growth of the global drug screening market. The prohibition on alcohol consumption in several Islamic nations has also had an impact on market demand. Concerns about the accuracy of breathalyzers have also contributed to the drug screening market's lackluster appeal.

Impact of COVID-19

The coronavirus outbreak has led to the downfall of many markets across the globe. Many industrial, manufacturing, production, and business development institutions were forced to shut down for an extended period of time due to nationwide lockdowns. The nationwide shutdown has had an impact on the availability of products and services to the drug screening business. As a result, the market's growth has slowed significantly. The market's progress was hampered by disruptions in the global supply chain and a supply-demand mismatch. Furthermore, with the healthcare sector's major focus on COVID-related cases, the number of drug and alcohol testing cases has plummeted, affecting demand from various end-use industries.

Drug Screening Market- By Products & Services

Based on products & services, the Drug Screening Market has been categorized into equipment, rapid testing devices, consumables, laboratory services, accessories, and others. For instance, coronavirus fast antigen testing kits became very popular during the pandemic. The rapid testing devices have been further segmented into oral fluid testing devices and urine testing devices. The urine testing devices segment held the largest share in the market in 2020. Also, the oral fluid testing devices segment is expected to contribute the highest market share during the forecast period. Urine testing devices are becoming more popular as a result of the useful services they provide, such as shorter detection times, quick results, non-invasive nature, and low risk of sample tampering.

Drug Screening Market- By End-Users

Based on end-users, the drug screening market has been categorized into workplace & schools, laboratories, criminal justice, hospital, drug testing laboratories, personal users, and others. In 2020, the workplace segment registered the largest market share. Pre-employment, reasonable suspicion, post-accident, return-to-duty, and monthly drug testing are some of the scenarios in which an organization conducts drug testing. The rise in the workplace segment is also due to increased concern over workplace security and performance. Thus, many organizations have made drug screening a mandatory process. For instance, as many as 90% of Fortune 200 companies currently use some kind of drug testing for their employees. However, issues have arisen in the past over how this practice is a violation of employees' privacy.

Drug Screening Market- Regional Insights

Based on region, the drug screening market is categorized into North America, Europe, the Asia-Pacific, Latin America, and the Middle East & Africa. North America dominated the global market with the largest share in 2020. Increased demand for drug screening has resulted from the alarming prevalence of illicit drug consumption in this region. Furthermore, the drug screening business in this region has grown as a result of government support and favorable policies aimed at reducing drug usage. For instance, The Army Substance Abuse Program is an anti-substance abuse program of the U.S. overseen by the Army Centre for Substance Abuse Program.

However, the Asia-Pacific region is expected to exhibit the highest growth in the global drug screening market during the forecast period. China and India have emerged as the highest growing economy for this market. The rising number of drug addicts, coupled with increased awareness of the importance of drug screening, and the development of improved technology for this industry are driving the market growth. According to a National Survey conducted by United Nations Office on Drugs and Crime, it was reported that 732 lakh people in India are users of alcohol and drugs.

Competitive Landscape

The Drug Screening Market is highly competitive and fragmented with international and regional players. The key players dominating the market are LabCorp, Quest Diagnostics, Abbott Rapid Diagnostics, OraSure Technologies, Alfa Scientific Designs, Thermo Fisher Scientific, Dragerwerk AG, Lifeloc Technologies, MPD Inc., Omega Laboratories, Premier Biotech Inc., Psychemedics Corporation, Roche AG, Shimadzu Corporation, Siemens Healthcare, BioMerieux SA, Synergy Health plc., CareHealth America Corporation, Biomedical Diagnostics, Agilent Technologies, and other prominent players. Routine screening initiatives and marketing activities, and programs carried out by some key players, such as Quest Technologies developing a Drug Testing Index, have improved their productivity. These strategies, along with new product launches, collaboration with government & organizations, and awareness campaigns, are adopted by companies to stay competitive in the market.

Recent Developments

• In June 2021, Amazon.com Inc announced that it supports the federal legalization of marijuana and has decided to drop marijuana-testing requirements for some sections of its workers.

• In May 2021, Quidel Corporation began selling its non-prescription QuickVue At-Home OTC COVID-19 Test online through Amazon in the United States.

Scope of Report:

Attribute	Details
Years Considered	Historical data – 2017-2020
	Base Year – 2020
	Forecast – 2021 – 2027
Facts Covered	Revenue in USD XXX Million
Market Coverage	The U.S., Canada, Germany, the U.K., France, Italy, Spain, Belgium, Netherlands, Russia, Brazil, Mexico, Argentina, Colombia, Japan, South Korea, China, India, Australia, New Zealand, UAE, South Africa, Saudi Arabia, Turkey, Kuwait, Qatar, Nigeria, Kenya, Iran
Product/Service Segmentation	By-Products & Services, By Sample Type, By End-User, and By Region
Key Players	Key players in the market include are LabCorp, Quest Diagnostics, Abbott Rapid Diagnostics, OraSure Technologies, Alfa Scientific Designs, Thermo Fisher Scientific, Dragerwerk AG, Lifeloc Technologies, MPD Inc., Omega Laboratories, Premier Biotech Inc., Psychemedics Corporation, Roche AG, Shimadzu Corporation, Siemens Healthcare, BioMerieux SA, Synergy Health plc., CareHealth America Corporation, Biomedical Diagnostics, Agilent Technologies, and other prominent players.

 

By Product & Service

•  Equipment

1. Immunoassay Analysers

2. Chromatography Instruments

3. Breath Analyzers

4. Other Devices

• Rapid Testing Devices

1. Urine Testing Devices

2. Oral Fluid Testing Devices

• Consumables

1. Assay Kits

• Laboratory Services

• Accessories

1. Sample Collection Cups

2. Calibrators and Controls

By Sample Type

• Oral Fluid or Saliva Sample

• Breath Sample

• Hair Sample

• Urine Sample

• Others

By End-User

• Workplace and Schools

• Criminal Justice System

• Hospitals

• Drug Testing Laboratories

• Personal Users

• Others

By Region

• North America

• Europe

• The Asia-Pacific

• Latin America

• Middle-East & Africa

 

1.    Research Framework

1.1. Research Objective

1.2. Product Overview

1.3. Market Segmentation

2.    Research Methodology

2.1. Qualitative Research

2.1.1.   Primary & Secondary Research

2.2. Quantitative Research

2.3. Market Breakdown & Data Triangulation

2.3.1.   Primary & Secondary Research End-use Industry

2.3.2.   Secondary Research

2.3.3.   Primary Research

2.4. Breakdown of Primary Research Respondents, By Region

2.5. Assumption & Limitation

3.    Executive Summary

4.    Global Drug Screening Market Insights

4.1. Industry Value Chain Analysis

4.2. DROC Analysis

4.2.1.   Growth Drivers

4.2.2.   Restraints

4.2.3.   Opportunities

4.2.4.   Challenges

4.3. Porter’s Five Forces Analysis

4.3.1.   Bargaining End-use Industry of Suppliers

4.3.2.   Bargaining End-use Industry of Buyers

4.3.3.   Threat of New Entrants

4.3.4.   Threat of Substitutes

4.3.5.   Intensity of Rivalry

4.4. Recent Development/ Technological Advancement

4.5. Regulatory Insights

5.    Global Drug Screening Market Overview

5.1. Market Size & Forecast by Value, 2017-2027

5.1.1.   By Value (USD Billion)        

5.2. Market Share & Forecast

5.2.1.   By Products & Services

5.2.1.1.       Equipment

5.2.1.1.1. Immunoassay Analyzers

5.2.1.1.2. Chromatography Instruments

5.2.1.1.3. Breath Analyzers

5.2.1.1.4. Others

5.2.1.2.       Rapid Testing Devices

5.2.1.2.1. Urine Testing Devices

5.2.1.2.2. Oral Fluid Testing Devices

5.2.1.2.3. Others

5.2.1.3.       Consumables

5.2.1.3.1. Assay Kits

5.2.1.4.       Laboratory Services

5.2.1.5.       Accessories

5.2.1.5.1. Calibrators and Controls

5.2.1.5.2. Sample Collection Cups

5.2.1.6.       Others

5.2.2.   By Sample Type

5.2.2.1 Oral Fluid or Saliva

5.2.2.2 Breath

5.2.2.3 Hair

5.2.2.4 Urine

5.2.2.5 Others

5.2.3.  By End-user

5.2.3.1. Workplace & Schools

5.2.3.2. Laboratories

5.2.3.3. Criminal Justice

5.2.3.4. Hospitals

5.2.3.5. Drug testing laboratories

5.2.3.6. Personal users

5.2.3.7. Others

           5.2.4. By Region

               5.2.4.1. North America

5.2.4.2. Europe

               5.2.4.3. Asia-Pacific

5.2.4.4. Latin America

               5.2.4.5. Middle East and Africa

6.    North Drug Screening Market

6.1. Market Size & Forecast by Value, 2017-2027

6.1.1.   By Value (USD Billion)

6.2. Market Share & Forecast

6.2.1.   By Products & Services

6.2.2.   By Sample Type

6.2.3.   By End-User

6.2.4.   By Country

6.2.4.1.     U.S.

6.2.4.2.     Canada

7.    Europe Drug Screening Market 

7.1. Market Size & Forecast by Value, 2017-2027

7.1.1.   By Value (USD Billion)

7.2. Market Share & Forecast

7.2.1.   By Products & Services

7.2.2.   By Sample Type

7.2.3.   By End-User

7.2.4.   By Country

7.2.4.1.       France

7.2.4.2.       Germany

7.2.4.3.       Italy

7.2.4.4.       Spain

7.2.4.5.       U.K.

7.2.4.6.       The Netherlands

7.2.4.7.       Belgium

7.2.4.8.       Russia

7.2.4.9.       NORDIC Countries

7.2.4.10.    Rest of Europe

8.    The Asia-Pacific (APAC) Drug Screening Market 

8.1. Market Size & Forecast by Value, 2017-2027

8.1.1.   By Value (USD Billion)

8.2. Market Share & Forecast

8.2.1.   By Products & Services

8.2.2.   By Sample Type

8.2.3.   By End-User

8.2.4.   By Country

8.2.4.1.     Japan

8.2.4.2.     China

8.2.4.3.     India

8.2.4.4.     South Korea

8.2.4.5.     Australia and New Zealand

8.2.4.6.     Southeast Asia Countries

8.2.4.7.     Rest of APAC

9.    Latin America Drug Screening Market

9.1. Market Size & Forecast by Value, 2017-2027

9.1.1.   By Value (USD Billion)

9.2. Market Share & Forecast

9.2.1.   By Products & Services

9.2.2.   By Sample Type

9.2.3.   By End-User

9.2.4.   By Country

9.2.4.1.     Brazil

9.2.4.2.     Argentina

9.2.4.3.     Mexico

9.2.4.4.     Colombia

9.2.4.5.     Rest of Latin America

10.The Middle East & Africa (MEA) Drug Screening Market

10.1.     Market Size & Forecast by Value, 2017-2027

10.1.1.    By Value (USD Billion)

10.2.     Market Share & Forecast

10.2.1.    By Products & Services

10.2.2.    By Sample Type

10.2.3.    By End-User

10.2.4.    By Country

10.2.4.1.    South Africa

10.2.4.2.    Saudi Arabia

10.2.4.3.    U.A.E.

10.2.4.4.    Qatar

10.2.4.5.    Kuwait

10.2.4.6.    Iran

10.2.4.7.    Turkey

10.2.4.8.    Rest of MEA

11.Competitive Landscape

11.1.     List of Key Players and their Offerings

11.2.     Company Market Share Analysis, 2020

11.3.     Competitive Benchmarking, By Operating Parameters

11.4.     Competitive Benchmarking, By Product Offerings

11.5.     Strategic Developments

12.Impact of Covid-19 across Global Drug Screening Market

13.Company Profile (Company Overview, Financial Matrix, Key Product landscape, Key Personnel, Key Competitors, Contact Address, and Strategic Outlook) *

 

13.1.     LabCorp

13.2.     Quest Diagnostics

13.3.     Abbott Rapid Diagnostics

13.4.     OraSure Technologies

13.5.     Alfa Scientific Designs

13.6.     Thermo Fisher Scientific

13.7.     Dragerwerk AG

13.8.     Lifeloc Technologies

13.9.     MPD Inc.

13.10.  Omega Laboratories

13.11.  Premier Biotech Inc.

13.12.  Psychemedics Corporation

13.13.  Roche AG

13.14.  Shimadzu Corporation

13.15.  Siemens Healthcare

13.16.  BioMerieux SA

13.17.  Synergy Health plc.

13.18.  CareHealth America Corporation

13.19.  Biomedical Diagnostics

13.20.  Agilent Technologies

13.21.  Other Prominent Players.

14.Key Strategic Recommendations

 

*Financial details of unlisted companies will be available as per data availability in the final deliverable

**The segmentation and the companies are subjected to modifications based on the in-depth secondary for the final deliverable

 

List of figures

Fig: Global Drug Screening Segmentation

 

Fig: Global Drug Screening Market Value Chain Analysis

 

Fig: Company Market Share Analysis, 2020

 

Fig: Global Drug Screening Market Size, By Value (USD Billion), 2017-2027

 

Fig: Global Drug Screening Market Share (%), By Products & Services, By Value, 2017-2027

 

Fig: Global Drug Screening Market Share (%), By Sample Type, By Value, 2017-2027

 

Fig: Global Drug Screening Market Share (%), By End-User, By Value, 2017-2027

 

Fig: Global Drug Screening Market Share (%), By Country, By Value, 2017-2027

 

Fig: North America Drug Screening Market Size, By Value (USD Billion), 2017-2027

 

Fig: North America Drug Screening Market Share (%), By Products & Services, By Value, 2017-2027

 

Fig: North America Drug Screening Market Share (%), By Sample Type, By Value, 2017-2027

 

Fig: North America Drug Screening Market Share (%), By End-User, By Value, 2017-2027

 

Fig: North America Drug Screening Market Share (%), By Country, By Value, 2017-2027

 

Fig: Europe Drug Screening Market Size, By Value (USD Billion), 2017-2027

 

Fig: Europe Drug Screening Market Share (%), By Products & Services, By Value, 2017-2027

 

Fig: Europe Drug Screening Market Share (%), By Sample Type, By Value, 2017-2027

 

Fig: Europe Drug Screening Market Share (%), By End-User, By Value, 2017-2027

 

Fig: Europe Drug Screening Market Share (%), By Country, By Value, 2017-2027

 

Fig: Asia-Pacific Drug Screening Market Size, By Value (USD Billion), 2017-2027

 

Fig: Asia-Pacific Drug Screening Market Share (%), By Products & Services, By Value, 2017-2027

 

Fig: Asia-Pacific Drug Screening Market Share (%), By Sample Type, By Value, 2017-2027

 

Fig: Asia-Pacific Drug Screening Market Share (%), By End-User, By Value, 2017-2027

 

Fig: Asia-Pacific Drug Screening Market Share (%), By Country, By Value, 2017-2027

 

Fig: Latin America Drug Screening Market Size, By Value (USD Billion), 2017-2027

 

Fig: Latin America Drug Screening Market Share (%), By Products & Services, By Value, 2017-2027

 

Fig: Latin America Drug Screening Market Share (%), By Sample Type, By Value, 2017-2027

 

Fig: Latin America Drug Screening Market Share (%), By End-User, By Value, 2017-2027

 

Fig: Latin America Drug Screening Market Share (%), By Country, By Value, 2017-2027

 

Fig: Middle East & Africa Drug Screening Market Size, By Value (USD Billion), 2017-2027

 

Fig: Middle East & Africa Drug Screening Market Share (%), By Products & Services, By Value, 2017-2027

 

Fig: Middle East & Africa Drug Screening Market Share (%), By Sample Type, By Value, 2017-2027

 

Fig: Middle East & Africa Drug Screening Market Share (%), By End-User, By Value, 2017-2027

 

Fig: Middle East & Africa Drug Screening Market Share (%), By Country, By Value, 2017-2027

 

 

 

 

 

List of Tables

 

Table: Global Drug Screening Market Size, By Products & Services, By Value, 2017-2027

 

Table: Global Drug Screening Market Size, By Sample Type, By Value, 2017-2027

 

Table: Global Drug Screening Market Size, By End-User, By Value, 2017-2027

 

Table: Global Drug Screening Market Size, By Region, By Value, 2017-2027

 

Table: North America Drug Screening Market Size, By Products & Services, By Value, 2017-2027

 

Table: North America Drug Screening Market Size, By Sample Type, By Value, 2017-2027

 

Table: North America Drug Screening Market Size, By End-User, By Value, 2017-2027

 

Table: North America Drug Screening Market Size, By Country, By Value, 2017-2027

 

Table: Europe Drug Screening Market Size, By Products & Services, By Value, 2017-2027

 

Table: Europe Drug Screening Market Size, By Sample Type, By Value, 2017-2027

 

Table: Europe Drug Screening Market Size, By End-User, By Value, 2017-2027

 

Table: Europe Drug Screening Market Size, By Country, By Value, 2017-2027

 

Table: Asia-Pacific Drug Screening Market Size, By Products & Services, By Value, 2017-2027

 

Table: Asia-Pacific Drug Screening Market Size, By Sample Type, By Value, 2017-2027

Table: Asia-Pacific Drug Screening Market Size, By End-User, By Value, 2017-2027

Table: Asia-Pacific Drug Screening Market Size, By Country, By Value, 2017-2027

Table: Latin America Drug Screening Market Size, By Products & Services, By Value, 2017-2027

Table: Latin America Drug Screening Market Size, By Sample Type, By Value, 2017-2027

Table: Latin America Drug Screening Market Size, By End-User, By Value, 2017-2027

Table: Latin America Drug Screening Market Size, By Country, By Value, 2017-2027

Table: Middle East & Africa Drug Screening Market Size, By Products & Services, By Value, 2017-2027

Table: Middle East & Africa Drug Screening Market Size, By Sample Type, By Value, 2017-2027

Table: Middle East & Africa Drug Screening Market Size, By End-User, By Value, 2017-2027

Table: Middle East & Africa Drug Screening Market Size, By Country, By Value, 2017-2027

 

Table: LabCorp Financial Analysis

Table: LabCorp Business Overview

Table: Quest Diagnostics Financial Analysis

Table:  Quest Diagnostics Business Overview

Table: Abbott Rapid Diagnostics Financial Analysis

Table: Abbott Rapid Diagnostics Business Overview

Table: OraSure Technologies Financial Analysis

Table: OraSure Technologies Business Overview

Table:  Alfa Scientific Designs Financial Analysis

Table:  Alfa Scientific Designs Business Overview

Table: Thermo Fisher Scientific Financial Analysis

Table: Thermo Fisher Scientific Business Overview

Table: Dragerwerk AG Financial Analysis

Table: Dragerwerk AG Business Overview

Table: Lifeloc Technologies Financial Analysis

Table: Lifeloc Technologies Business Overview

Table: MPD Inc.Financial Analysis

Table: MPD Inc.Business Overview

Table: Omega LaboratoriesFinancial Analysis

Table:  Omega LaboratoriesBusiness Overview

Table:  Premier Biotech Inc. Financial Analysis

Table:  Premier Biotech Inc. Business Overview

Table:  Psychemedics Corporation Financial Analysis

Table:  Psychemedics Corporation Business Overview